Veracyte Inc.

S&P 500

VCYT/Healthcare · Diagnostics & Research/NASDAQ

Stock Price

$58.55

Stock Price$58.55P/E49.3MCap4.2BLast update: Jun 26, 2026 at 06:56

Dividend Safety Rating

N/A/ 100

Dividend Safety Rating

VCYT does not currently pay a dividend. The Dividend Safety Rating is not applicable for non-dividend stocks.

About Veracyte Inc.

Veracyte Inc. is a global diagnostics company specializing in advanced genomic tests that provide clinicians with precise insights to diagnose and treat cancer. Its portfolio features key products such as Afirma for thyroid cancer, Decipher Prostate and Decipher Bladder for prostate and bladder cancers respectively, Prosigna for breast cancer, Envisia for interstitial lung diseases including idiopathic pulmonary fibrosis, and Percepta for lung cancer diagnosis. These molecular diagnostics leverage genomic sequencing, machine learning, and clinical data through the company's innovative Veracyte Diagnostics Platform, enabling AI-assisted analysis and evidence generation to support personalized treatment decisions and avoid unnecessary surgeries. Veracyte Inc. operates centralized CLIA labs in the US and offers distributed in vitro diagnostics for international markets across North America, Europe, and the Middle East, serving healthcare providers, biopharmaceutical partners, and biotechnology sectors. Founded in 2006 and headquartered in South San Francisco, California, the company plays a vital role in precision oncology by transforming cancer care with actionable genomic information at critical decision points.

Dividend Overview

Dividend Yield

0.00%

Annual Dividend

$0.00

Frequency

N/A

Payout Ratio

0.00%

FCF Payout Ratio

0.00%

52-Week Range

$22.61 - $60.28

Earnings & Profitability

VCYT earnings per share and net profit margin

Key Dates

Next Ex-Dividend Date

—

Next Payment Date

—

Dividend Growth

3-Year Dividend CAGR

N/A

5-Year Dividend CAGR

N/A

10-Year Dividend CAGR

N/A

3-Year Total Growth

N/A

5-Year Total Growth

N/A

10-Year Total Growth

N/A

Income Calculator

VCYT Dividend Calculator

Number of Shares

Total Investment

$5,855.00

Annual Income

$0.00

Quarterly Income

$0.00

Monthly Income

$0.00

Frequently Asked Questions

What is VCYT's current dividend yield?

Veracyte Inc. (VCYT) currently has a dividend yield of 0.00%, based on a stock price of $58.55 and an annual dividend of $0.00.

When is VCYT's next dividend payment date?

VCYT's next ex-dividend date is — and the next payment date is —. You must own the stock before the ex-dividend date to receive the upcoming payment.

How much does VCYT pay in dividends per year?

Veracyte Inc. pays dividends unknown. Annual dividend data is not yet available.

Has VCYT been increasing its dividend?

Veracyte Inc. has grown its dividend at a 5-year CAGR of —.

Is VCYT's dividend safe?

Veracyte Inc. has a payout ratio of 0.00%. Its free cash flow payout ratio is 0.00%. A payout ratio below 60% is generally considered sustainable.

How is VCYT's Dividend Safety Rating calculated?

The Dividend Safety Rating evaluates Veracyte Inc.'s dividend sustainability across four categories: Payout & Coverage (30%), Balance Sheet (20%), Profitability (20%), and Dividend Track Record (30%). Each metric is rated from "Very Safe" to "Danger" based on industry-standard thresholds, with sector-specific adjustments for healthcare companies. The overall score ranges from 0 to 100.

Want to understand how we rate dividend safety? Read our full methodology

Track VCYT Dividends with OnlyDividends

What will VCYT actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.

This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.

Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Safety Rating, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.

Market data provided by Twelve Data.